This article describes the design and validation of a general procedure for the high-throughput isolation of amylosucrase variants displaying higher thermostability or increased resistance to organic solvents. This procedure consists of 2 successive steps: an in vivo selection that eliminates inactive variants followed by automated screening of active variants to isolate mutants displaying enhanced features. The authors chose an Escherichia coli expression vector, allowing a high production rate of the recombinant enzyme in miniaturized culture conditions. The screening assay was validated by minimizing variability for various parameters of the protocol, especially bacterial growth and protein production in cultures in 96-well microplates. Recombinant amylosucrase production was normalized by decreasing the coefficient of variance from 27% to 12.5%. Selective screening conditions were defined to select variants displaying higher thermostability or increased resistance to organic solvents. A first-generation amylosucrase variant library, constructed by random mutagenesis, was subjected to this procedure, yielding a mutant displaying a 25-fold increased stability at 50 °C compared to the parental wild-type enzyme. (Journal of Biomolecular Screening 2007:715-723) 
INTRODUCTION
D IRECTED EVOLUTION is a powerful approach for generating enzymes with desired properties, such as improved catalytic activities, new substrate specificities, and catalytic activities under extreme conditions such as high temperature or organic solvents. 1 This strategy consists of isolating protein variants displaying an improvement for the property of interest through iterative steps of random mutagenesis, DNA recombination, selection, and/or screening. Libraries of mutant genes can be generated by a large variety of generic methods, such as chemical mutagenesis, error-prone PCR, or DNA shuffling. 2 In contrast, selection and screening procedures need to be designed for each enzyme and reaction. Moreover, the size of the libraries created through mutagenesis and/or recombination processes is usually larger than the number of protein variants that can be screened. The same limitation is applicable in the case of cDNA or genomic libraries derived from natural sources, for which diversity is practically unlimited. Therefore, the design of reliable high-throughput selection and screening methods that discriminate efficiently mutant enzymes displaying desired properties among the available diversity without selecting false positives is a critical point for the success of directed evolution experiments.
Amylosucrase from Neisseria polysaccharea (AS, EC 2.4.1.4) is a glucansucrase from glycoside hydrolase (GH) family 13 that catalyzes the synthesis of a water-insoluble amylose-like polymer from sucrose, a readily available and low-cost agroresource. 3, 4 Contrary to starch or glycogen synthases, 5 this enzyme does not require expensive nucleotide-activated sugar as a glucosyl donor. Furthermore, this enzyme is able to glucosylate various exogenous acceptors, mostly oligo-or polysaccharides, following a transglucosylation reaction that occurs at the cost of sucrose hydrolysis and polymer synthesis. 6, 7 AS is thus an attractive biocatalyst for the industrial synthesis of amylose-like polymers, the modification of polysaccharides such as glycogen, or the production of oligosaccharides. 8, 9 Meanwhile, its use as an industrial tool is limited by its low thermostability (t 1/2 = 3 min at 50 °C) and its weak resistance toward organic solvents. In addition, further application developments such as synthesis of longer amylose chains at higher temperatures or in the presence of organic solvent clearly require adapting AS to these harsher conditions.
A directed evolution approach has already been initiated to optimize AS activity. 10, 11 A zero background cloning strategy, the pCEASE system, was developed and used to clone a firstgeneration AS variant library (containing approximately 50,000 clones). An in vivo selection protocol to discard inactive variants was described. The dinitrosalicylic acid (DNS) method for the measure of reducing sugar production 12 and iodine staining to detect amylose formation 13 were miniaturized in the 96-well microplate format to provide an activity screening method. Preliminary small-scale screening assays on reduced sets of active variants (60 or 90) allowed the isolation of mutants with 1.5-to 2-fold increased activity. However, this approach was not convenient to screen wider libraries. The major drawback of this method was the low level of recombinant enzyme produced using the pCEASE system, which was not suitable to develop accurate and fast screening assays.
Here we report the choice of a more efficient expression system to miniaturize recombinant AS production in 96-well microplates. Using this system, we describe the optimization of an automated screening procedure designed to isolate from AS variant libraries mutant enzymes displaying higher thermostability or increased resistance to organic solvents. The screening assay was validated by minimizing variability for various parameters of the protocol, including bacterial growth or protein production in the microplate culture. Finally, the whole validated procedure was tested by screening a first-generation AS variant library created by random mutagenesis.
MATERIALS AND METHODS

Bacterial strains and plasmids
One Shot ® Escherichia coli TOP10 (Invitrogen, Carlsbad, CA) was used for transformation of ligation mixtures. E. coli JM109 (Promega, Madison, WI) was used to screen AS variants and large-scale production of the selected mutants. Plasmid pGST-AS, derived from pGEX-6P-3 (Amersham Pharmacia Biotech, Piscataway, NJ), was used for the construction, selection, and screening of the AS random mutagenesis library and for the production of glutathione S-transferase (GST)-amylosucrase fusion proteins (expression of AS under control of the tac promoter). 4 Plasmid pCEASE01, expressing amylosucrase under the control of the lac promoter, was described elsewhere. 10 Bacterial cells were grown on LB (agar) containing 50 µg/mL kanamycin (when harboring pCEASE01) or 100 µg/mL ampicillin (when harboring pGEX-6P-3-derived plasmid). For expression of amylosucrase in E. coli, JM109 media were supplemented with 1 mM isopropyl-β-D-thiogalactose (IPTG).
DNA manipulations
A library of random mutants using AS as parent type was created following the MutaGen random mutagenesis technique developed by MilleGen (Labège, France) and described elsewhere. 14 Restriction endonucleases and DNA-modifying enzymes were purchased from New England Biolabs (Ipswich, MA) and used according to the manufacturer's instructions. DNA purification was performed using QIAQuick (PCR purification and gel extraction) and QIASpin (miniprep and maxiprep) (Qiagen, Valencia, CA). DNA sequencing was carried out using the dideoxy chain termination procedure by the MilleGen sequencing service.
Selection of active amylosucrase-expressing clones
Following transformation with pCEASE01, pGST-AS (wild type or E328Q inactive mutant), and the random mutagenesis library, E. coli JM109 cells were plated on solid LB containing the appropriate antibiotic. After growth, the cells were scraped and diluted in physiological water to an OD 600 of 10 -4 . The clones were then subjected to selection pressure by plating them onto solid M9 medium (42 mM Na 2 HPO 4 , 24 mM KH 2 PO 4 , 9 mM NaCl, 19 mM NH 4 Cl, 1 mM MgSO 4 , 0.5 µg/mL thiamine) containing 50 g/L sucrose as the sole carbon source, the appropriate antibiotic, and 1 mM IPTG when needed. The plates were incubated for 3 to 5 days at 30 °C to obtain sufficient cell growth linked to expression of active amylosucrase.
Storage of individual active amylosucrase-expressing clones
Automated selective colony picking was carried out using colony picker QpixII (Genetix, Hampshire, UK), which can reach a cadence of 4000 colonies per hour according to 5 criteria: colony diameter, roundness, proximity, contrast with the solid medium, and color. Colonies were transferred to sterile 96well microplates (Nunc™ Brand Products, Roskilde, Denmark) filled with 150 µL LB medium using a Biomek2000 pipettor (Beckman, Fullerton, CA). After 24 h of growth at 30 °C under horizontal shaking (250 rpm) on an incubator-shaker (Kühner, Basel, Switzerland), microplate wells were filled with 100 µL sterile glycerol 30% (v/v) and stored at -20 °C. These microplates are referred to as storage microplates.
Growth conditions in microplates
Storage microplates were initially replicated using the QpixII automate to start cultures for recombinant AS production in sterile 96-well microplates (Nunc™ Brand Products; per well: 200 µL LB, 1 mM IPTG) grown for 18 h at 30 °C under agitation. These microplates (referred to as production microplates) were then used for enzyme activity determination.
After modifying the procedure, storage microplates were used to inoculate cultures in 96-well microplates referred to as starter microplates (150 µL LB per well). After growth for 24 h at 30 °C under agitation, these plates were duplicated using QpixII to start production cultures in a 96-well format grown at 30 °C for 24 h under agitation (according to the finalized protocol).
Cell density levels at the end of growth incubation were measured by recording the OD 600 for each well using a TECAN (Maennedorf, Switzerland) Sunrise microplate reader. To analyze growth during time incubation, a production microplate culture was grown, and at regular time intervals, OD 600 was measured for 3 randomly chosen wells.
Enzyme activity determination in microplate
Bacterial lysis was performed by adding lysozyme into production cultures to a final concentration of 0.5 g/L and freezing the cells at -80 °C for 8 to 12 h. After thawing for 1 h at room temperature, the clones were screened using an integrated robotic TECAN Genesis RSP-200 platform, allowing liquid transfers, microplate and lid movements, barcode reading, incubation, shaking, and spectrophotometric reading of the microplates. After transfer of 80 µL of crude cell extracts in a nonsterile 96-well microplate (Barloworld Scientific, Staffordshire, UK), enzymatic reaction was carried out by adding 80 µL of sucrose to a final concentration of 146 mM followed by incubation at 37 °C for 4 h. Reducing-sugar production was measured by adding 50 µL of the reaction mixture to 50 µL of the dinitrosalicylic acid (DNS) reagent 12 in a polypropylene microplate (Evergreen Scientific, Los Angeles, CA), incubating 25 min at 75 °C on a microplate heater, adding 100 µL H 2 O, transferring 120 µL in a polystyrene flat-bottom microplate (Barloworld Scientific), adding 120 µL H 2 O, and measuring the absorbance at 540 nm with the Sunrise microplate reader.
When screening for thermostability, a heat treatment step (20 min, 50 °C) was performed before adding sucrose. For screening activity under organic solvents, DMSO was added in the reaction mixture to a final concentration of 30% or 50% (v/v; 160 µL final reaction volume).
Activity data collected under screening conditions were analyzed using Microsoft Excel. The coefficient of variance (CV) was calculated using experimental data as follows: CV = (standard deviation/mean) × 100%.
Production, purification, and thermostability comparison of wild-type and variant AS
Production and purification of wild-type and variant AS were performed as previously described. 15 Because pure GST-AS fusion protein possesses the same function and the same efficiency as pure AS (data not shown), enzymes were purified simply to the GST-AS fusion protein stage (96 kDa). The enzymes (wild type or mutated) were obtained and stored in elution buffer (50 mM Tris-HCl [pH 7.0], 150 mM NaCl, 1 mM EDTA, 1 mM dithiothreitol). The protein content was determined by the micro-Bradford method, using bovine serum albumin as a standard. 16 Half-lives of thermal inactivation were determined for purified wild-type and variant GST-AS by incubating the enzymes (0.5 mg/mL) at 50 °C for various time intervals. Initial and residual activities were measured at 37 °C with 146 mM sucrose in phosphate-buffered saline (PBS) buffer at pH 7.3 using the DNS method to quantify the released reducing sugar. Enzyme half-lives were deduced by fitting the neperian logarithm of relative residual activity versus time curves.
RESULTS AND DISCUSSION
Choice of the recombinant AS expression system
To improve the sensitivity of the screening assay, we attempted to use a more efficient expression system than pCEASE. The pGEX vector, enabling production of recombinant protein with an N-terminal GST fusion, is routinely used for the production and the purification of AS and its variants. Gene expression in this vector is under the control of the synthetic tac promoter, which allows higher protein production levels than that obtained when the as gene is under the control of the lac promoter. Indeed, in flask culture (50 mL), cells possessing pGST-AS produce 50 times more enzyme than those harboring pCEASE01, as reflected by the difference in activity levels measured on sucrose at 30 °C from sonicated cell extracts (200 U/L culture vs. 5 U/L culture ). We compared the expression levels of both systems in 96-well microplates to verify that this ratio was not affected when scaling down the culture conditions. The difference in activity levels obtained from flask cultures was maintained in 96-well microplates. The mean activity per well from crude cell extracts harboring pGST-AS was 143 U/L culture versus 19 U/L culture with pCEASE01. Therefore, we chose to use the pGEX expression vector for further directed evolution experiments involving AS.
The general procedure designed to analyze AS variant libraries includes an in vivo selection step eliminating clone-expressing inactive mutants followed by an automated screen. This procedure was optimized for the use of the chosen expression system, especially to reduce the variability of the microplate activity assay.
Genetic selection for clones expressing active amylosucrase
Selection for E. coli cells harboring active AS variant is based on the fact that K12-derived strains cannot metabolize sucrose. 17 Therefore, the use of a minimal medium containing sucrose as a sole carbon source allows the selection of E. coli clones producing an active AS variant because the enzyme cleaves sucrose, releasing fructose, which can be metabolized. AS variants displaying only hydrolytic activity would also be selected following this method. The initial protocol developed using the pCEASE system 10 was adapted for the use of the stronger pGEX expression system. Indeed, pGST-AS E. coli cells did not grow when IPTG (inducer) was present in the selective media, whereas cells containing pCEASE01 do. However, E. coli cells possessing pGST-AS were able to develop on a selective medium without inducer. Actually, GST-AS overexpression induced by IPTG seems to result in a toxic effect by limiting bacterial growth. Basal expression of GST-AS without inducer is sufficient to complement E. coli cells on selective sucrose medium. These results were validated by using an inactive AS variant (E328Q) expressing clone as a negative control.
Optimization of reproducible and automated screening conditions
Our objective was to validate a reliable and fast highthroughput screening (HTS) protocol. Therefore, automation was systematically employed to standardize and accelerate different stages of the screening process, such as bacterial inoculation, microplate filling up, and the activity assay. However, reproducibility is not only based on the use of robots. A screening procedure consists of several steps, including cell growth, gene expression, bacterial lysis, and the activity assay. The errors within each step are reflected in the variability of the activity data finally collected. This variability is linked to the ability of the screening procedure to identify significantly improved variants and not false positives. The coefficient of variance (CV = (standard deviation/mean) × 100%) is a useful statistical parameter to estimate the reproducibility or dispersion of the data obtained from the screening. The wide data dispersal obtained using a screening with a high CV (above 20%) does not allow an accurate comparison between variants (Fig. 1) . Given a threshold value above which a variant can be considered as improved, the probability of retaining false positives increases with CV value. Therefore, the CV value should be as low as possible (less than 15%). To determine and decrease this parameter, we tested the screening conditions by analyzing the activity data collected from 96-well microplates containing clones expressing wild-type AS (parental enzyme).
Definition of experimental conditions for normalized cell growth and recombinant AS expression
To assay the initial screening conditions (see Materials and Methods), cultures in the 96-well format were inoculated by replicating storage microplates containing E. coli clones harboring pGST-AS. These cultures were grown under induction to allow recombinant GST-AS expression. After bacterial lysis, crude cell extracts were assayed for AS activity on sucrose at 37 °C. A CV of approximately 27% (n = 288; 3 microplates) was determined from this experiment. Figure 2B represents the AS activities measured in 1 representative microplate. A wide dispersal of the activity levels and important differences between wells were observed in this graph. This showed that the initial screening protocol was not reproducible for each clone (well) assayed. To analyze growth conditions, cell density of the microplate cultures was measured before lysis. Bacterial turbidity is a rather difficult parameter to study at the microplate scale. Indeed, microplate cultures were read directly without dilution or resuspension; therefore, cell sedimentation in some wells during growth cannot be circumvented and introduces more or less uncertainty in measurements. However, the cell density profile of a representative microplate ( Fig. 2A) was quite informative about the fact that growth conditions were not reproducible between microplate wells. The comparison of growth ( Fig. 2A) and activity (Fig. 2B) showed that in some wells, no growth or activity was measured (generally 3-10 wells per microplate), whereas in others, activity was not detected even when growth was observed. Thus, the initial conditions of the screening procedure needed to be modified to normalize bacterial growth and protein expression levels. The study of these parameters was of importance to estimate the effect of downscaling a protocol we routinely perform in flask cultures. The presence of inducer (IPTG) in culture medium is necessary to obtain high enzyme production rates when using the pGEX expression system. However, it is also likely to limit bacterial growth. According to the initial protocol, clones arranged in a storage microplate (thawed cell suspensions) were replicated to inoculate a production microplate filled with LB medium containing IPTG (see Materials and Methods). Those drastic conditions can explain the variability observed for bacterial growth and consequently for protein expression and activity. Indeed, limited growth (or absence of growth) in some wells was not observed when inoculating cultures in the 96-well format without inducer, but AS activity was not detectable in those conditions (data not shown). To circumvent this problem caused by a combination of inoculation and culture conditions, we considered the possibility of using fresh cultures in a 96-well format to inoculate the production microplates. Therefore, a step consisting of launching starter 96-well cultures without inducer from storage microplates was added to the initial procedure. A set of experiments using clones expressing wild-type AS was performed to define new experimental conditions for this modified protocol and to analyze its reproducibility.
As a first observation, the use of starter cultures in the 96well format improved the inoculation efficiency of microplate cultures induced for protein production. More normalized growth levels were obtained with this new procedure (Fig. 2C) compared to the initial protocol ( Fig. 2A) . Moreover, absence of growth in some wells was not observed using this method.
Growth kinetics was studied by analyzing a production culture in a 96-well format replicated from a starter microplate (Fig. 3A) . found to be much lower compared to that observed in routine flask cultures (dotted line). Stationary phase was reached after 30 h of incubation. Indeed, miniaturized culture conditions were more restrictive, especially for aeration. To relate this growth profile to enzyme expression, microplate cultures launched under the same conditions were incubated for different times, subjected to lysis, and then assayed for AS activity on sucrose at 37 °C. In agreement with the growth rate observed in microplates, the results presented in Figure 3B showed that nearly 24 h of culture were needed to reach GST-AS production levels (reflected by activity calculation) similar to those obtained routinely in flask cultures (~200 U per liter of culture). As liquid evaporation is not negligible for culture in the 96-well format, growth above 24 h was not assayed. The CV values determined using the activity data collected from these validation experiments were below 15%, indicating that improving the inoculation efficiency was needed to allow more reproducibility in the whole screening procedure. A standardized activity profile with a CV of 12.5% (Fig.  2D) was defined using the new procedure. These results show significantly how protein expression levels can be normalized in cultures in the 96-well format by modifying bacterial growth parameters.
These results allowed defining the experimental conditions for standardized growth and GST-AS expression in cultures in the 96-well format (Fig. 4B) . Moreover, performing the activity assay on an integrated robotic platform ensures the screening of 1344 clones (14 microplates) per day.
Conditions for screening thermostable AS variants
AS activity optimum is reached for temperatures around 37 °C, and no activity is measurable above 50 °C. However, performing the enzymatic assay at temperatures higher than 45 °C was not suited to screen for thermostable AS variants because liquid evaporation introduces errors in activity determination. Therefore, assaying residual activity at 37 °C after incubation at an elevated temperature (20 min at 50 °C) was a more convenient method to measure enzyme thermostability. Using growth and expression conditions defined previously, this screening procedure was applied on 6 microplates containing wild-type ASexpressing clones. As shown in Figure 5A , the heat treatment resulted in the total denaturation of wild-type AS. The CV of this screening protocol was 9.5%, indicating that this additional incubation step did not affect reproducibility.
Conditions for screening AS variants in organic cosolvents
Two critical points have to be studied when setting up screening conditions for AS activity in the presence of organic solvents. First, the chosen media must be able to solubilize both sucrose and amylose. Second, the concentration of these media has to be defined to allow the detection of small enhancements due to single amino acid substitutions during screening experiments. DMSO and water-DMSO mixtures have been widely used as dispersing and solubilizing agents for starch and starch components, especially for size exclusion chromatography analysis. 18 DMSO was also found to enable solubilization of sucrose. 19 Moreover, the purified wild-type AS initial rate was not affected in the presence of 30% DMSO, but the enzyme was shown to rapidly lose its activity (Anne Bertrand, personal communication, 2006) .
The screening procedure was simulated using microplates containing clones expressing wild-type AS. Following bacterial lysis, crude extracts were assayed for AS activity in the presence of 30% or 50% DMSO. As shown in Figure 5B , crude extracts retain approximately 10% of AS total activity in the presence of 30% DMSO, whereas no activity is detected in 50% DMSO. The CV for both conditions was below 10% (n = 96).
Screening a first-generation AS variant library
A first-generation AS variant library was constructed using the MutaGen technique 14 with conditions introducing randomly ~10 mutations per kb and cloned into pGEX-6P3. Transformation of this library in E. coli TOP10 yielded approximately 100,000 clones. Scraping the colonies from the solid medium and plasmid purification allowed library storage under the form of a plasmid solution.
The library was subjected to selection with sucrose as the sole carbon source. Approximately 2700 active AS-expressing clones (28 microplates) from these selective plates were picked to inoculate cultures in the 96-well format that were stored at -20 °C after growth. This library of individualized active ASexpressing clones was then screened for thermostability following the protocol defined in the present study. One clone was found to be more thermostable among the ensemble of variants analyzed ( Fig. 6) and was selected for preliminary characterizations to further confirm its properties. The sequencing of this variant showed that it contains 4 DNA mutations compared to the wild-type sequence, leading to 1 single amino acid substitution, P351S ( Table 1) . Wild-type and variant P351S GST-AS proteins were purified to measure half-lives at 50 °C. Whereas the wild-type enzyme immediately denatures (t 1/2~ 1 min), the P351S variant displays a half-life of 25 min (Fig. 7) , thus confirming that this mutant is not a false positive. However, when screening these 2700 AS variants in the presence of 30% or 50% DMSO, none showed increased activity or stability compared to the parental wild-type enzyme. Screening a higher amount of variants could be a possible solution. Meanwhile, this result reflects the difficulty of performing successful directed evolution experiments when using screening conditions displaying strong stringency. Therefore, using less selective screening conditions (below 30% DMSO, for example) at the first round of the directed evolution process could enable the detection of mutants featuring small enhancements. A gradual increase of the screening stringency during the next rounds would then make it possible to find evolutionary trajectories that lead to the desired enhancement of the property of interest. The critical point of this strategy resides in the correct definition of the screening conditions for each round of the directed evolution experiment.
CONCLUSION
A general selection and HTS procedure is provided for the analysis of gene libraries of amylosucrase variants. As summarized in Figure 4A , this procedure consists of 2 successive steps: an in vivo selection, which eliminates inactive variants, followed by an automated screening of active variants to isolate mutants displaying better thermostability or improved activity in organic cosolvents. To minimize variability, each step of the procedure was standardized and automated when possible. A set of experiments performed with wild-type AS-expressing clones minimized the variability within critical stages of the selection and screening procedure, thus reducing the probability of selecting false positives when screening a variant library. Finally, the validated procedure was used to analyze a first-generation AS variant library, which led to the selection of a mutant displaying improved thermostability. This standardized procedure will now be applied to screen second-and third-generation libraries and provide even more thermostable AS. Regarding the isolation of AS variants more stable in organic solvent, our preliminary screening clearly indicates that less stringent conditions have to be employed during the screening of first-generation libraries. 
